Comparing DRD2 Promoter Methylation Between Blood and Brain in Alcohol Dependence
- 6 February 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 58 (2) , 216-223
Abstract
Aims: The dopamine receptor D2 (DRD2) is substantially involved in several forms of addiction. In addition to genetic polymorphisms, epigenetic mechanisms have emerged as an important means of regulation. Previously, DRD2 hypo- and hyper-methylation have been observed in alcohol use disorder (AUD). Blood samples are commonly used as a surrogate marker of epigenetic alterations in epigenetic research, but few specific comparisons between blood and brain tissue samples in AUD exist.Methods: We used post-mortem brain tissue samples of 17 deceased patients with AUD and 31 deceased controls to investigate the relationship between blood and brain methylation of the DRD2 promoter.Results: When investigating individual cytosine methylation sites (CpG), several significant differences were found in the nucleus accumbens and hippocampus in the study population. Investigating binding sites with significant differences in methylation levels revealed hypomethylated CpGs targeting mainly activating transcription factors.Conclusion: These findings support an altered transcription of the DRD2 gene in AUD specimens with a consecutively changed reward response in the brain. While methylation between specific brain regions and blood is comparable, our study further suggests that blood methylation cannot provide meaningful perspectives on DRD2 promoter methylation in the brain.Keywords
This publication has 42 references indexed in Scilit:
- Transcriptional Activation of the Human CD2AP Promoter by E2F1PLOS ONE, 2012
- Positron Emission Tomography Molecular Imaging of Dopaminergic System in Drug AddictionThe Anatomical Record, 2012
- Gene Coexpression Networks in Human Brain Identify Epigenetic Modifications in Alcohol DependenceThe Journal of Neuroscience, 2012
- Genetics of alcohol dependencePsychiatry and Clinical Neurosciences, 2011
- Sex Differences in the Brain, Behavior, and Neuropsychiatric DisordersThe Neuroscientist, 2010
- Sex Differences in Striatal Dopamine Release in Young Adults After Oral Alcohol Challenge: A Positron Emission Tomography Imaging Study With [11C]RacloprideBiological Psychiatry, 2010
- The Wilms’ tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytesJournal of Cellular and Molecular Medicine, 2009
- Sp1 and Sp3 activate transcription of the human dopamine transporter geneJournal of Neurochemistry, 2005
- Site‐specific cytosine methylation in S‐COMT promoter in 31 brain regions with implications for studies involving schizophreniaAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Neuroendocrine pathways of addictive behaviourAddiction Biology, 2004